Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR Test Systems director Rhea J. Posedel exercised 18,000 non-qualified options on October 20, 2026, at an exercise price of $1.77 per share, acquiring 18,000 common shares. Her direct common-share position following the transaction was 65,156 shares, including shares subject to unvested restricted stock units. The filing also lists 381,989 common shares held indirectly by trust. No Rule 10b5-1 plan is reported.
At AEHR Test Systems’ October 19, 2026 annual meeting, shareholders elected Rhea J. Posedel, Gayn Erickson, Fariba Danesh, Laura Oliphant, Geoffrey G. Scott and Howard T. Slayen as directors. Each will serve until the next annual meeting or until a successor is elected and qualified, subject to earlier departure as described in the company’s terms.
Shareholders ratified BPM LLP as the independent registered public accounting firm for the fiscal year ending June 25, 2027, and approved named executive officer compensation on a non-binding, advisory basis. Of 32,659,546 shares entitled to vote, 22,928,987 were present in person or by proxy.
AEHR Test Systems CFO Chris Siu had 987 common shares withheld at a reported $84.64 per share on October 12, 2026, to satisfy tax withholding obligations upon vesting of restricted stock units; the footnote says this was not a sale. His reported direct holdings afterward were 74,983 shares, including shares subject to unvested restricted stock units. He also reported 6,795 shares held indirectly by trust.
At AEHR TEST SYSTEMS (AEHR), Alistair N. Sporck, VP Contactor Business Unit, had 295 common shares withheld on October 12, 2026 to satisfy tax withholding obligations upon vesting of restricted stock units; the footnote says this was not a sale. The reported price per share was $84.64. His reported direct position afterward was 21,853 shares, including shares subject to unvested restricted stock units. He also reported 6,398 common shares held by trust.
Vernon Rogers, AEHR Test Systems' Exec VP of Sales & Mktg., had 426 shares withheld to satisfy tax withholding obligations upon vesting of restricted stock units on October 12, 2026; this did not represent a sale. His reported direct position afterward was 186,879 shares, including shares subject to unvested restricted stock units.
AEHR Test Systems CTO Donald P. Richmond II reported a tax-withholding disposition of 388 shares on October 12, 2026; the shares were withheld to satisfy tax obligations upon vesting of restricted stock units. The reported price was $84.64 per share, and the footnote states this was not a sale. His reported post-transaction amount was 186,728 shares, including shares subject to unvested restricted stock units.
AEHR Test Systems Chief Operating Officer Adil Engineer reported that 547 shares were withheld on October 12, 2026, to satisfy tax-withholding obligations upon restricted stock unit vesting; the footnote states this was not a sale. The reported price was $84.64 per share. His reported post-transaction amount was 45,942 shares, including shares subject to unvested restricted stock units.
AEHR Test Systems President and CEO Gayn Erickson had 2,675 common shares withheld on October 12, 2026, to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares; the footnote states this was not a sale. His reported direct position after the transaction was 191,108 shares, including shares subject to unvested restricted stock units and unvested restricted shares. A separate holding entry lists 158,776 shares held indirectly by trust.
Aehr Test Systems President and CEO and director Gayn Erickson reported 3,239 shares withheld on October 2, 2026, to satisfy tax-withholding obligations upon vesting of restricted stock units and restricted shares; a footnote says this was not a sale. Reported holdings afterward were 193,783 shares directly, including shares subject to unvested restricted stock units and unvested restricted shares, and 158,776 shares indirectly through a trust.
AEHR Test Systems Chief Operating Officer Adil Engineer reported 620 shares withheld on October 2, 2026, to satisfy tax-withholding obligations upon vesting of restricted stock units and restricted shares. The transaction was not a sale. His reported post-transaction position was 46,489 shares, including shares subject to unvested restricted stock units.